A Study to Evaluate Drug-drug Interactions Between BR1017-1 and BR1017-2 in Healthy Volunteers

Clinical trial NCT05372380 · COMPLETED

Trial details

NCT number: NCT05372380
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension Hypercholesterinemia

Start date: 2022-05-09
Primary completion: 2022-06-04
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.